Phenominer Database Results (18 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
BN/Cub serum triglyceride level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 300 days 6 47.79 mg/dl 3.61 8.85 liquid phase colorimetry retroorbital plexus 0.0 0 70214 1318
BN/Cub serum insulin level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 310 days 6 0.08 mg/dl 0.02 0.04 radioimmunoassay retroorbital plexus 0.0 0 70279 1318
BN/Cub serum uric acid level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 300 days 6 72.3 umol/l 1.55 3.8 liquid phase colorimetry retroorbital plexus 0.0 0 70281 1318
BN/Cub serum uric acid level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 307 days 6 101.8 umol/l 4.78 11.7 liquid phase colorimetry retroorbital plexus 0.0 0 70283 1318
BN/Cub serum glucose level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 310 days 6 252.29 mg/dl 28.16 68.97 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70241 1318
BN/Cub serum glucose level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 300 days 6 78.05 mg/dl 1.48 3.63 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70237 1318
BN/Cub serum free fatty acids level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 310 days 6 1.4 mmol/l 0.08 0.2 liquid phase colorimetry retroorbital plexus 0.0 0 70235 1318
BN/Cub serum free fatty acids level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 300 days 6 1.12 mmol/l 0.08 0.2 liquid phase colorimetry retroorbital plexus 0.0 0 70229 1318
BN/Cub serum free fatty acids level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 307 days 6 1.26 mmol/l 0.08 0.2 liquid phase colorimetry retroorbital plexus 0.0 0 70231 1318
BN/Cub serum insulin level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 307 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70277 1318
BN/Cub serum triglyceride level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 310 days 6 46.9 mg/dl 3.61 8.85 liquid phase colorimetry retroorbital plexus 0.0 0 70220 1318
BN/Cub blood glucose level area under curve (AUC) fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 300 days 6 14454.55 (mg/dl) x min 247.18 605.45 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70269 1318
BN/Cub serum triglyceride level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 307 days 6 61.95 mg/dl 7.23 17.7 liquid phase colorimetry retroorbital plexus 0.0 0 70216 1318
BN/Cub blood glucose level area under curve (AUC) controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 307 days 6 15850.91 (mg/dl) x min 1065.16 2609.09 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70271 1318
BN/Cub blood glucose level area under curve (AUC) controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 310 days 6 42156.36 (mg/dl) x min 1723.55 4221.82 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70273 1318
BN/Cub serum insulin level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 300 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70275 1318
BN/Cub serum uric acid level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 310 days 6 107.3 umol/l 3.18 7.8 liquid phase colorimetry retroorbital plexus 0.0 0 70285 1318
BN/Cub serum glucose level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 307 days 6 74.42 mg/dl 3.7 9.07 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70239 1318